BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Pacira BioSciences Reports First Quarter 2026 Financial Results

  April 30, 2026

   · 

  30 min read
• Press Releases

  Emergent BioSolutions Reports First Quarter 2026 Financial Results

  April 30, 2026

   · 

  35 min read
• Press Releases

  TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

  April 30, 2026

   · 

  9 min read
• Press Releases

  Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update

  April 30, 2026

   · 

  10 min read
• Press Releases

  Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results

  April 30, 2026

   · 

  10 min read
• Press Releases

  DBV Technologies Reports First Quarter 2026 Financial Results

  April 30, 2026

   · 

  9 min read
• Press Releases

  Alvotech Announces a Change in its Executive Team

  April 30, 2026

   · 

  2 min read
• Press Releases

  Nephros Schedules First Quarter 2026 Financial Results Conference Call

  April 30, 2026

   · 

  1 min read
• Press Releases

  Valneva Announces the Successful Completion of an €84 million Reserved Offering

  April 30, 2026

   · 

  19 min read
• Press Releases

  D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types

  April 30, 2026

   · 

  5 min read